NCT03127020
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Medizinische Klinik und Poliklinik III Munich, Bavaria, Germany
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,082 public trials
2,050 recruiting studies
Lymphoproliferative Disorders trial results
NCT02401048
- Conditions
- Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Site-0397 Birmingham, Alabama, United States
- Site-0047 Duarte, California, United States
- Site-0038 Stanford, California, United States
- Site-0388 Miami, Florida, United States
Completed
Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas
NCT01898078
- Conditions
- Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- The Bronx, New York, United States
- Nashville, Tennessee, United States
- San Antonio, Texas, United States
NCT02213263
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Pacific Cancer Medical Center, Inc. Anaheim, California, United States
- The Oncology Institute of Hope and Innovation Anaheim, California, United States
- Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
- The Oncology Institute of Hope and Innovation Downey, California, United States
NCT01506453
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT02488369
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Gustave Roussy Cancer Campus Grand Paris Villejuif, Val De Marne, France
Completed
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT02176213
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT02624492
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Jessa Ziekenhuis - Campus Virga Jesse Hasselt, Belgium
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- Istituto Clinico Humanitas Rozzano (MI), Italy
- A. O. S. Maria della Misericordia Udine, Italy
NCT00634881
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany
- Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany
- Universitatsklinikum Heidelberg Heidelberg, Germany
- Klinikum Lippe - Lemgo Lemgo, Germany
NCT00153920
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States